🇺🇸 FDA
Patent

US 9644216

Adeno-associated virus vectors for treatment of glycogen storage disease

granted A61KA61K48/0008A61K48/005

Quick answer

US patent 9644216 (Adeno-associated virus vectors for treatment of glycogen storage disease) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K48/0008, A61K48/005, A61K48/0066, A61K48/0075